In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Baker Hughes trades 8.1% above a high-confidence fair value estimate, with significant valuation dispersion across DCF, P/E, and analyst targets indicating mixed market views. Financial health shows strong profitability and leverage but weak growth, while Monte Carlo analysis reveals high volatility and substantial downside risk (63.9%). The broad scenario range ($25.06–$263.05) reflects considerable uncertainty amid stable liquidity and efficiency.